Simbex vs Phillips-Medisize: full comparison for 2026
Quick verdict
Simbex (3.9/5) edges ahead of Phillips-Medisize (3.9/5) overall. Simbex is the better choice for sensor wearables and biomechanics research. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Simbex vs Phillips-Medisize: head-to-head summary
| Criterion | Simbex | Phillips-Medisize |
|---|---|---|
| Founded | 2000 | 1964 |
| HQ | Lebanon, NH, USA | Hudson, WI, USA |
| Team size | 11–100 | ~7,000 |
| Rating | 3.9 / 5 | 3.9 / 5 |
| Primary differentiator | Biomechanics and sensor research background applied to wearable health devices | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Time and materials, fixed project | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | BLE, Embedded C/C++, Sensor fusion | Injection molding, Automated assembly, BLE |
| Industries served | Wearables & remote monitoring, Sports technology, Digital health | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Simbex vs Phillips-Medisize: overview
Simbex
Simbex was founded in 2000 in Lebanon, New Hampshire, and works on product design, applied research and commercialization in medtech, health tech and sports technology. Riddell, the American football helmet maker and a long-time client, acquired it in April 2024. Its medical work includes RestEaze, a remote monitoring device for sleep disorder diagnosis built with Tanzen Medical, and fall-detection wearables. Team size estimates range from 11 to 100.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Simbex vs Phillips-Medisize
| Capability | Simbex | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✓ | ✗ |
| Industrial design & human factors | ✓ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✗ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Simbex vs Phillips-Medisize
| Framework / platform | Simbex | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | ✓ | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Simbex vs Phillips-Medisize
| Criterion | Simbex | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Simbex vs Phillips-Medisize
| Dimension | Simbex | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Wearables & remote monitoring, Sports technology, Digital health | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Sensor-based wearable for remote monitoring, Biomechanics research study for a device concept | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Fixed project | Fixed project |
Simbex vs Phillips-Medisize: pros and cons
| Simbex | |
|---|---|
| + | Strong sensor and biomechanics research skills |
| + | Experience with wearable monitoring devices |
| + | Covers design through commercialization planning |
| + | Small team with direct access to principals |
| - | Owned by Riddell since April 2024, so sports technology may take priority over medical clients |
| - | Small team |
| - | Fewer regulated Class II and III device credits than medtech-only firms |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Simbex?
A typical fit: sensor-based wearable for remote monitoring.
Biomechanics and sensor research background applied to wearable health devices. Minimum engagement is not publicly disclosed. Works best with clients in Wearables & remote monitoring, Sports technology, Digital health.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Simbex vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Simbex |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Simbex (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Simbex |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Simbex vs Phillips-Medisize
| Use case | Simbex fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Sensor-based wearable for remote monitoring | Strong | Limited | Simbex |
| Biomechanics research study for a device concept | Strong | Limited | Simbex |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Simbex vs Phillips-Medisize
Simbex (3.9/5) is the stronger overall choice for most Medical Device Development projects. Biomechanics and sensor research background applied to wearable health devices.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Simbex vs Phillips-Medisize FAQ
Is Simbex better than Phillips-Medisize?
Simbex (3.9/5) scores higher overall, but "better" depends on your use case. Simbex's strongest advantage: strong sensor and biomechanics research skills. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Simbex and Phillips-Medisize differ in pricing?
Simbex uses time and materials, fixed project pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Simbex or Phillips-Medisize?
Simbex is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Simbex and Phillips-Medisize?
Simbex's primary differentiator is: biomechanics and sensor research background applied to wearable health devices. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (11–100 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Wearables & remote monitoring, Sports technology vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.